Possible roles of sestrin2 in multiple sclerosis and its relationships with clinical outcomes.

Faruk Omer Odabas Ali Ulvi Uca Turan Akdağ Filiz Demirdögen Mustafa Altaş Osman Serhat Tokgoz

Published in: Arquivos de neuro-psiquiatria (2022)

The decreased expression of SESN2 may play a role in MS pathogenesis, and SESN2 could be used as a biomarker for MS and as immunotherapeutic agent to treat MS.

Keyphrases

multiple sclerosis
mass spectrometry
ms ms
white matter
poor prognosis